metricas
covid
Annals of Hepatology P- 18 TREATMENT WITH BEVACIZUMAB IN HIGH OUTPUT CARDIAC FAILURE DUE TO SEVERE HE...
Journal Information

Statistics

Follow this link to access the full text of the article

P- 18 TREATMENT WITH BEVACIZUMAB IN HIGH OUTPUT CARDIAC FAILURE DUE TO SEVERE HEPATIC COMPROMISE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA PATIENTS: OBSERVATIONAL COHORT STUDY
Carolina Vazquez1,2, Juan Bandi1,3,4, Marcelo Serra1,2,4
1 A.R.G Argentine Rendu Study Group. Italian Hospital, Buenos Aires, Argentina
2 Internal Medicine Department. Italian Hospital, Buenos Aires, Argentina
3 Hepatology Section. Italian Hospital, Buenos Aires, Argentina
4 Hereditary Hemorrhagic Telangiectasia Unit. Italian Hospital, Buenos Aires, Argentina
Read
717
Times
was read the article
260
Total PDF
457
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 34 2 36
2025 11 44 22 66
2025 10 36 20 56
2025 9 38 16 54
2025 8 27 21 48
2025 7 26 9 35
2025 6 24 4 28
2025 5 12 2 14
2025 4 26 7 33
2025 3 16 1 17
2025 2 14 6 20
2025 1 20 20 40
2024 12 13 4 17
2024 11 15 4 19
2024 10 9 6 15
2024 9 10 4 14
2024 8 16 5 21
2024 7 14 3 17
2024 6 10 3 13
2024 5 10 2 12
2024 4 7 4 11
2024 3 4 6 10
2024 2 7 5 12
2024 1 5 8 13
2023 12 2 3 5
2023 11 4 3 7
2023 10 5 33 38
2023 9 1 11 12
2023 8 5 4 9
2023 7 1 3 4
2023 6 2 9 11
2023 5 0 10 10
Show all

Follow this link to access the full text of the article